Breaking News Instant updates and real-time market news.

XLRN

Acceleron

$44.67

0.75 (1.71%)

22:05
09/16/19
09/16
22:05
09/16/19
22:05

Acceleron's ACE-083 program was high risk, says Piper Jaffray

Piper Jaffray analyst Danielle Brill kept her Overweight rating and $71 price target on Acceleron after its ACE-083 agent failed to meet its primary endpoint in the Phase 2 proof-of-concept facioscapulohumeral muscular dystrophy, or FSHD, trial. The analyst contends that the program was already high risk and that her model did not assign it any value, adding that she would buy any weakness in the stock given the company's other near-term catalysts are expected to drive "significant upside."

  • 17

    Oct

  • 04

    Dec

  • 04

    Apr

XLRN Acceleron
$44.67

0.75 (1.71%)

05/10/19
HCWC
05/10/19
NO CHANGE
HCWC
Acceleron price target raised to $69 from $66 at H.C. Wainwright
H.C. Wainwright analyst Edward White maintained a Buy rating on Acceleron Pharma and raised his price target on shares to $69 from $66 after the company reported Q1 results. The analyst noted he continues to expect "approval and commercial success for luspatercept" and sees luspatercept sales totalling $164M in 2020, implying $32.8M in royalties for Acceleron.
05/24/19
SBSH
05/24/19
INITIATION
Target $66
SBSH
Buy
Citi assumes Acceleron at Buy, sees 'significant' upside potential
Citi analyst Yigal Nochomovitz assumed coverage of Acceleron Pharma with a Buy rating and boosted his price target for the shares to $66 from $63. The analyst sees potential for "significant" share upside over the next 12-18 months with lead drug Luspatercept launching in early 2020, catalysts from Luspatercept expansion and an evolving pipeline.
05/29/19
GSCO
05/29/19
INITIATION
Target $54
GSCO
Neutral
Acceleron assumed with a Neutral at Goldman Sachs
Goldman Sachs analyst Paul Choi assumed coverage of Acceleron Pharma with a Neutral rating and $54 price target. Prior analyst Terence Flynn had a Neutral rating on the shares with a $40 price target. Choi believes the launch of luspatercept will be the primary driver of stock performance over the next 12 months, and his estimates are broadly in-line with the consensus.
09/06/19
HCWC
09/06/19
NO CHANGE
Target $69
HCWC
Buy
H.C. Wainwright backs Buy rating on Acceleron after sotatercept gets ODD
H.C. Wainwright analyst Edward White maintained a Buy rating and $69 price target on Acceleron Pharma after sotatercept received orphan drug designation from the FDA for the treatment of patients with pulmonary arterial hypertension. In a research note to investors, White says Acceleron is evaluating sotatercept in PAH patients in the randomized, double blind, placebo-controlled PULSAR Phase 2 trial, which is assessing sotatercept plus standard of care versus placebo plus SoC in participants with PAH of WHO Group 1, functional class II-III. White says topline results for the PULSAR trial are expected in the first quarter of 2020, while the Phase 2 SPECTRA exploratory trial in adult PAH patients that receive SoC plus sotatercept for a 24 week treatment period followed by a 16 week follow up period is enrolling and is expected to have preliminary results in 2020.

TODAY'S FREE FLY STORIES

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
10/18/19
10/18
10:17
10/18/19
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
10/18/19
10/18
10:16
10/18/19
10:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:15
10/18/19
10/18
10:15
10/18/19
10:15
Conference/Events
JPMorgan autos/auto parts analyst to hold an analyst/industry conference call »

Autos & Auto Parts…

10:15
10/18/19
10/18
10:15
10/18/19
10:15
General news
U.S. leading economic index dipped -0.1% to 111.9 in September »

U.S. leading economic…

10:15
10/18/19
10/18
10:15
10/18/19
10:15
General news
Breaking General news story  »

Minneapolis Federal…

NIO

NIO Inc.

$1.48

0.01 (0.68%)

10:10
10/18/19
10/18
10:10
10/18/19
10:10
Options
Nov 1.5 put seller in NIO cashes out 140% winner »

Nov 1.5 put seller in NIO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IRET

Investors Real Estate

$76.60

0.75 (0.99%)

, PINS

Pinterest

$25.86

-0.14 (-0.54%)

10:06
10/18/19
10/18
10:06
10/18/19
10:06
Initiation
Fly Intel: Top five analyst initiations »

Catch up on today's…

IRET

Investors Real Estate

$76.60

0.75 (0.99%)

PINS

Pinterest

$25.86

-0.14 (-0.54%)

SNAP

Snap

$14.00

0.22 (1.60%)

IDN

Intellicheck

$5.00

(0.00%)

WBT

Welbilt

$17.97

(0.00%)

DAVA

Endava

$40.06

-0.01 (-0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 31

    Oct

  • 05

    Nov

  • 07

    Nov

  • 11

    Nov

  • 12

    Nov

  • 19

    Nov

  • 20

    Nov

  • 21

    Nov

  • 04

    Dec

  • 05

    Dec

  • 16

    Oct

GIL

Gildan Activewear

$25.88

-9.495 (-26.84%)

, CAT

Caterpillar

$131.37

1.36 (1.05%)

10:06
10/18/19
10/18
10:06
10/18/19
10:06
Downgrade
Fly Intel: Top five analyst downgrades »

Catch up on today's…

GIL

Gildan Activewear

$25.88

-9.495 (-26.84%)

CAT

Caterpillar

$131.37

1.36 (1.05%)

CRL

Charles River

$135.10

-0.97 (-0.71%)

M

Macy's

$14.98

-0.79 (-5.01%)

LB

L Brands

$16.56

-1.54 (-8.51%)

GPS

Gap

$16.53

-1.05 (-5.97%)

WM

Waste Management

$115.34

-0.97 (-0.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 23

    Oct

  • 31

    Oct

  • 04

    Nov

  • 21

    Nov

  • 21

    Nov

  • 21

    Nov

MO

Altria Group

$44.40

0.14 (0.32%)

, SNAP

Snap

$13.99

0.21 (1.52%)

10:06
10/18/19
10/18
10:06
10/18/19
10:06
Upgrade
Fly Intel: Top five analyst upgrades »

Catch up on today's…

MO

Altria Group

$44.40

0.14 (0.32%)

SNAP

Snap

$13.99

0.21 (1.52%)

CMG

Chipotle

$846.04

17.95 (2.17%)

RSG

Republic Services

$87.30

1.15 (1.33%)

WCN

Waste Connections

$92.97

0.7 (0.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 22

    Oct

  • 29

    Oct

  • 30

    Oct

  • 31

    Oct

  • 12

    Nov

STT

State Street

$60.83

1.12 (1.88%)

10:05
10/18/19
10/18
10:05
10/18/19
10:05
Hot Stocks
State Street says reigniting servicing fee revenue growth remains a top priority »

Comments taken from the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

10:02
10/18/19
10/18
10:02
10/18/19
10:02
General news
Leading Indicators data reported »

September Leading…

SXT

Sensient

$60.60

-5.97 (-8.97%)

10:00
10/18/19
10/18
10:00
10/18/19
10:00
Hot Stocks
Sensient falls -8.8% »

Sensient is down -8.8%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

NNA

Navios Acquisition

$8.58

-1.78 (-17.18%)

10:00
10/18/19
10/18
10:00
10/18/19
10:00
Hot Stocks
Navios Acquisition falls -17.6% »

Navios Acquisition is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GIL

Gildan Activewear

$26.26

-9.12 (-25.78%)

10:00
10/18/19
10/18
10:00
10/18/19
10:00
Hot Stocks
Gildan Activewear falls -25.8% »

Gildan Activewear is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

X

U.S. Steel

$10.67

0.05 (0.47%)

10:00
10/18/19
10/18
10:00
10/18/19
10:00
Options
Size put buyer in US Steel March 8 strike »

Size put buyer in US…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HEP

Holly Energy Partners

$22.40

1.13 (5.31%)

10:00
10/18/19
10/18
10:00
10/18/19
10:00
Hot Stocks
Holly Energy Partners rises 5.3% »

Holly Energy Partners is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

KSU

Kansas City Southern

$143.50

8.17 (6.04%)

10:00
10/18/19
10/18
10:00
10/18/19
10:00
Hot Stocks
Kansas City Southern rises 6.0% »

Kansas City Southern is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 13

    Nov

BORR

Borr Drilling

$6.57

0.53 (8.77%)

10:00
10/18/19
10/18
10:00
10/18/19
10:00
Hot Stocks
Borr Drilling rises 9.7% »

Borr Drilling is up 9.7%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GIL

Gildan Activewear

$26.54

-8.835 (-24.98%)

09:59
10/18/19
10/18
09:59
10/18/19
09:59
Downgrade
Gildan Activewear rating change  »

BofA/Merrill double…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

JNJ

Johnson & Johnson

$132.71

-3.49 (-2.56%)

09:55
10/18/19
10/18
09:55
10/18/19
09:55
Options
Johnson & Johnson put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

PBCT

People's United

$16.17

0.41 (2.60%)

, KSU

Kansas City Southern

$141.65

6.32 (4.67%)

09:55
10/18/19
10/18
09:55
10/18/19
09:55
Options
Early notable gainers among liquid option names on October 18th »

Notable gainers among…

PBCT

People's United

$16.17

0.41 (2.60%)

KSU

Kansas City Southern

$141.65

6.32 (4.67%)

APA

Apache

$23.24

1.12 (5.06%)

ETFC

E-Trade

$40.84

1.8 (4.61%)

ISRG

Intuitive Surgical

$552.97

23.75 (4.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 19

    Oct

  • 27

    Oct

  • 31

    Oct

  • 13

    Nov

AMZN

Amazon.com

$1,785.24

-2.6 (-0.15%)

, MSFT

Microsoft

$139.65

-0.03 (-0.02%)

09:55
10/18/19
10/18
09:55
10/18/19
09:55
Conference/Events
Deutsche Bank TMT analyst to hold an analyst/industry conference call »

Tech, Media & Telecom…

AMZN

Amazon.com

$1,785.24

-2.6 (-0.15%)

MSFT

Microsoft

$139.65

-0.03 (-0.02%)

GOOG

Alphabet

$1,256.30

3.51 (0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 23

    Oct

  • 24

    Oct

  • 26

    Oct

  • 27

    Oct

  • 28

    Oct

  • 29

    Oct

  • 06

    Nov

  • 21

    Nov

CRM

Salesforce

$145.81

-0.36 (-0.25%)

09:50
10/18/19
10/18
09:50
10/18/19
09:50
Conference/Events
Economic Club of Washington, D.C. to hold luncheon meeting »

The Economic Club of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Dec

MRK

Merck

$84.14

0.34 (0.41%)

09:47
10/18/19
10/18
09:47
10/18/19
09:47
Recommendations
Merck analyst commentary  »

Merck's Keytruda…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 23

    Oct

  • 29

    Oct

  • 06

    Nov

  • 18

    Nov

  • 07

    Dec

  • 24

    Jan

  • 24

    Jan

  • 14

    Mar

NNA

Navios Acquisition

$8.51

-1.85 (-17.86%)

09:47
10/18/19
10/18
09:47
10/18/19
09:47
Hot Stocks
Navios Acquisition falls -18.3% »

Navios Acquisition is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.